Korea’s leading drug manufacturers feel pinch in prescription drug sales

Published: 2011-01-24 07:00:00

Updated: 2011-01-24 07:00:00

Last year, the leading domestic drug makers were significantly affected by the government’s policy to abandon rebate, defined by a kind of kickback given by drug companies to pharmacies, clinics and hospital for buying their products.

These companies, such as Daewoong Pharmaceutical, Dong-A Ph...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK